Candesartan Tablet
Product Images NDC 71335-3032

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Candesartan (NDC 71335-3032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Candesartan Figure1s)

1 (Candesartan Figure1s)
This is a list of demographic and medical information for patients in a study, including age, sex, race, medical history, and treatment options. The data appears to be related to a clinical trial comparing the effectiveness of different medications. The hazard ratio is also mentioned, indicating the risk of an event happening in one group compared to another.*
FDA Label Image

1 (Candesartan Structure1s)

1 (Candesartan Structure1s)
This text describes a chemical structure, likely relating to a reaction involving ester hydrolysis. It mentions the presence of certain functional groups and the site of the hydrolysis reaction.*
FDA Label Image

Label (Lbl713353032)

Label (Lbl713353032)
This text is a package insert for tablets containing Candesartan Cilexetil 16 mg. It provides information on usual dosage, storage instructions, and manufacturer details. The QR code can be scanned for detailed Dosage and Administration instructions. The tablets are to be stored at a temperature between 20°C to 25°C and can be excursed between 15°C to 30°C. The product is intended for prescription use only and comes in a package containing 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.